Reported 1,445,493 shares, down 940,450 (39.4%) from the prior quarter.
Reported value -36.9%; share count -39.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-03-31 | 44384388 |
| 2024-06-30 | 61942523 |
| 2024-09-30 | 69773645 |
| 2024-12-31 | 75436259 |
| 2025-03-31 | 90509510 |
| 2025-06-30 | 104003081 |
| 2025-09-30 | 102956319 |
| 2025-12-31 | 113167982 |
| 2026-03-31 | 125962648 |
| 2026-06-30 | 133779824 |
| 2026-09-30 | 84358971 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 1,445,493 | -940,450 (-39.4%) | 5.5% | $84,358,971 | 2026-11-05 | |
| Q2 2026 | Reduced | 2,385,943 | -239,920 (-9.1%) | 5.87% | $133,779,824 | 2026-08-10 | |
| Q1 2026 | Reduced | 2,625,863 | -302,915 (-10.3%) | 6.04% | $125,962,648 | 2026-05-13 | |
| Q4 2025 | Added | 2,928,778 | +10,515 (0.4%) | 5.21% | $113,167,982 | 2026-02-12 | |
| Q3 2025 | Added | 2,918,263 | +31,694 (1.1%) | 4.69% | $102,956,319 | 2025-11-06 | |
| Q2 2025 | Reduced | 2,886,569 | -20,900 (-0.7%) | 5.04% | $104,003,081 | 2025-08-13 | |
| Q1 2025 | Reduced | 2,907,469 | -49,656 (-1.7%) | 4.36% | $90,509,510 | 2025-04-28 | |
| Q4 2024 | Added | 2,957,125 | +490,754 (19.9%) | 3.18% | $75,436,259 | 2025-02-06 | |
| Q3 2024 | Added | 2,466,371 | +117,394 (5.0%) | 2.85% | $69,773,645 | 2024-11-05 | |
| Q2 2024 | Added | 2,348,977 | +887,522 (60.7%) | 2.77% | $61,942,523 | 2024-08-06 | |
| Q1 2024 | New | 1,461,455 | +1,461,455 (0.0%) | 1.86% | $44,384,388 | 2024-05-07 |
Who else reported the position
752 managers reported ROYALTY PHARMA PLC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | Reduced | 41,100,185 | -1,831,412 | 0.12% | $2,398,606,956 | 26 qtrs |
| Capital International Investors | Reduced | 33,897,019 | -1,376,751 | 0.41% | $1,978,230,029 | 6 qtrs |
| BlackRock Inc | Added | 29,117,396 | +1,284,419 | 0.03% | $1,699,291,230 | 9 qtrs |
| FMR LLC | Reduced | 19,348,880 | -5,164,934 | 0.05% | $1,129,200,661 | 26 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 14,712,137 | +3,518,480 | 0.09% | $858,601,000 | 26 qtrs |
| STATE STREET CORPORATION | Added | 12,951,600 | +613,371 | 0.02% | $755,855,376 | 26 qtrs |
| Swedbank AB | Reduced | 10,260,593 | -466,015 | 0.51% | $598,808,207 | 22 qtrs |
| BAILLIE GIFFORD & CO | Reduced | 9,151,948 | -863,630 | 0.5% | $534,107,685 | 19 qtrs |
| Capital World Investors | Reduced | 8,755,768 | -761,569 | 0.06% | $510,986,620 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 8,546,758 | +488,710 | 0.03% | $497,512,565 | 26 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 05, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,147,513
- Shared
- 0
- None
- 297,980
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.